Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics

被引:1
|
作者
Wei, Shengcai [1 ]
Gou, Xinyi [1 ]
Zhang, Yinli [2 ]
Cui, Jingjing [3 ]
Liu, Xiaoming [4 ]
Hong, Nan [1 ]
Sheng, Weiqi [5 ,6 ]
Cheng, Jin [1 ]
Wang, Yi [1 ]
机构
[1] Peking Univ, Dept Radiol, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R China
[2] Peking Univ, Peoples Hosp, Dept Pathol, 11 Xizhimen South St, Beijing 100044, Peoples R China
[3] United Imaging Intelligence Beijing Co Ltd, Dept Res & Dev, Yongteng North Rd, Beijing 100094, Peoples R China
[4] Beijing United Imaging Res Inst Intelligent Imagin, Dept Res & Dev, Yongteng North Rd, Beijing 100089, Peoples R China
[5] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China
[6] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
关键词
Colorectal liver metastases; Histopathologic growth pattens; Radiomics; Chemotherapy; PROGNOSIS; RESECTION; SURVIVAL; CANCER;
D O I
10.1007/s10585-024-10275-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemotherapy alters the prognostic biomarker histopathological growth pattern (HGP) phenotype in colorectal liver metastases (CRLMs) patients. We aimed to develop a CT-based radiomics model to predict the transformation of the HGP phenotype after chemotherapy. This study included 181 patients with 298 CRLMs who underwent preoperative contrast-enhanced CT followed by partial hepatectomy between January 2007 and July 2022 at two institutions. HGPs were categorized as pure desmoplastic HGP (pdHGP) or non-pdHGP. The samples were allocated to training, internal validation, and external validation cohorts comprising 153, 65, and 29 CRLMs, respectively. Radiomics analysis was performed on pre-enhanced, arterial phase, portal venous phase (PVP), and fused images. The model was used to predict prechemotherapy HGPs in 112 CRLMs, and HGP transformation was analysed by comparing these findings with postchemotherapy HGPs determined pathologically. The prevalence of pdHGP was 19.8% (23/116) and 45.8% (70/153) in chemonaive and postchemotherapy patients, respectively (P < 0.001). The PVP radiomics signature showed good performance in distinguishing pdHGP from non-pdHGPs (AUCs of 0.906, 0.877, and 0.805 in the training, internal validation, and external validation cohorts, respectively). The prevalence of prechemotherapy pdHGP predicted by the radiomics model was 33.0% (37/112), and the prevalence of postchemotherapy pdHGP according to the pathological analysis was 47.3% (53/112; P = 0.029). The transformation of HGP was bidirectional, with 15.2% (17/112) of CRLMs transforming from prechemotherapy pdHGP to postchemotherapy non-pdHGP and 30.4% (34/112) transforming from prechemotherapy non-pdHGP to postchemotherapy pdHGP (P = 0.005). CT-based radiomics method can be used to effectively predict the HGP transformation in chemotherapy-treated CRLM patients, thereby providing a basis for treatment decisions.
引用
收藏
页码:143 / 154
页数:12
相关论文
共 50 条
  • [31] Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment
    Fiz, Francesco
    Costa, Guido
    Gennaro, Nicolo
    la Bella, Ludovico
    Boichuk, Alexandra
    Sollini, Martina
    Politi, Letterio S.
    Balzarini, Luca
    Torzilli, Guido
    Chiti, Arturo
    Vigano, Luca
    DIAGNOSTICS, 2021, 11 (07)
  • [32] CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection
    Wang, Fang
    Chen, Qingqing
    Zhang, Yuanyuan
    Chen, Yinan
    Zhu, Yajing
    Zhou, Wei
    Liang, Xiao
    Yang, Yunjun
    Hu, Hongjie
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 453 - 465
  • [33] Radiomics and Machine Learning Analysis Based on Magnetic Resonance Imaging in the Assessment of Colorectal Liver Metastases Growth Pattern
    Granata, Vincenza
    Fusco, Roberta
    De Muzio, Federica
    Cutolo, Carmen
    Raso, Mauro Mattace
    Gabelloni, Michela
    Avallone, Antonio
    Ottaiano, Alessandro
    Tatangelo, Fabiana
    Brunese, Maria Chiara
    Miele, Vittorio
    Izzo, Francesco
    Petrillo, Antonella
    DIAGNOSTICS, 2022, 12 (05)
  • [34] Histopathological growth patterns and positive margins after resection of colorectal liver metastases
    Nierop, Pieter M. H.
    Hoppener, Diederik J.
    van der Stok, Eric P.
    Galjart, Boris
    Buisman, Florian E.
    Balachandran, Vinod P.
    Jarnagin, William R.
    Kingham, T. Peter
    Allen, Peter J.
    Shia, Jinru
    Vermeulen, Peter B.
    Koerkamp, Bas Groot
    Grunhagen, Dirk J.
    Verhoef, Cornelis
    D'Angelica, Michael, I
    HPB, 2020, 22 (06) : 911 - 919
  • [35] Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases
    Wei, Jingwei
    Cheng, Jin
    Gu, Dongsheng
    Chai, Fan
    Hong, Nan
    Wang, Yi
    Tian, Jie
    MEDICAL PHYSICS, 2021, 48 (01) : 513 - 522
  • [36] A CT-based radiomics approach to predict immediate response of radiofrequency ablation in colorectal cancer lung metastases
    Huang, Haozhe
    Zheng, Dezhong
    Chen, Hong
    Chen, Chao
    Wang, Ying
    Xu, Lichao
    Wang, Yaohui
    He, Xinhong
    Yang, Yuanyuan
    Li, Wentao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases
    Hewitt, Daniel Brock
    Pawlik, Timothy M.
    Cloyd, Jordan M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 2931 - 2933
  • [38] Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases
    Daniel Brock Hewitt
    Timothy M. Pawlik
    Jordan M. Cloyd
    Annals of Surgical Oncology, 2021, 28 : 2931 - 2933
  • [39] An innovative radiomics approach to predict response to chemotherapy of liver metastases based on CT images
    Giannini, Valentina
    Defeudis, Arianna
    Rosati, Samanta
    Cappello, Giovanni
    Mazzetti, Simone
    Panic, Jovana
    Regge, Daniele
    Balestra, Gabriella
    42ND ANNUAL INTERNATIONAL CONFERENCES OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY: ENABLING INNOVATIVE TECHNOLOGIES FOR GLOBAL HEALTHCARE EMBC'20, 2020, : 1339 - 1342
  • [40] Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases
    Florian E. Buisman
    Eric P. van der Stok
    Boris Galjart
    Peter B. Vermeulen
    Vinod P. Balachandran
    Robert R. J. Coebergh van den Braak
    John M. Creasy
    Diederik J. Höppener
    William R. Jarnagin
    T. Peter Kingham
    Pieter M. H. Nierop
    Eran Sadot
    Jinru Shia
    Bas Groot Koerkamp
    Dirk J. Grünhagen
    Michael D’Angelica
    Cornelis Verhoef
    Clinical & Experimental Metastasis, 2020, 37 : 593 - 605